| 4.95 Data as of May 17 |  +0.25 / +5.32%Today’s Change | 3.20 Today|||52-Week Range 7.08 | +6.91% Year-to-Date |
| Previous close | 4.70 |
| Today’s open | 4.74 |
| Day’s range | 4.67 - 4.99 |
| Volume | 141,263 |
| Average volume (3 months) | 85,882 |
| Market cap | $178.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +55.61% |
| Earnings growth (this year) | +19.54% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +11.81% |
| P/E ratio | NM |
| Price/Sales | 2.11 |
| Price/Book | 2.45 |
| Today’s change | Today’s % change | |
|---|---|---|
| ATECAlphatec Holdings In... | +0.04 | +2.05% |
| MDCIMedical Action Indus... | -0.16 | -1.86% |
| DSCIDerma Sciences Inc | -0.06 | -0.42% |
| RTIXRTI Biologics Inc | -0.05 | -1.14% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $76.2M |
| Annual profit (last year) | -$30.1M |
| Net profit margin | -39.56% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Mark J. Foley |
Senior Vice President- Operations Richard W. Poinsett, MBA |
Corporate headquarters Pleasanton, California |
.
